Keywords
Vulgar Acne
Pediatrics
How to Cite
Abstract
Isotretinoin, or 13-cis-retinoic acid, is a retinoid derived from vitamin A widely used in the treatment of severe cases of acne and other dermatological conditions.
This drug is distinguished by its ability to act on multiple pathophysiological aspects of acne, such as reducing the size and activity of the sebaceous glands, reducing colonization by Cutibacterium acnes and attenuating inflammation. These actions not only achieve significant acne control during treatment, but may also offer a sustained long-term effect due to structural remodeling of the sebaceous glands, which decreases recurrence.
Acne is a disease that can leave physical and psychological scars, so early and effective treatment is essential to prevent these complications, improving the quality of life of these patients.
Although the treatment of moderate-severe acne is usually conducted by a dermatologist, acne isotretinoina we believe it is important that pediatricians become familiar with this drug, its indications, the most frequent adverse effects, as well as the complications that may arise.
References
Eichenfield D, Sprague J, Eichenfield L. Management of acne vulgaris: a review. JAMA 2021; 326(20):2055-67. doi: 10.1001/jama.2021.17633.
Paichitrojjana A. Oral isotretinoin and its uses in dermatology: a review. Drug Des Devel Ther 2023; 17:2573-91. doi: 10.2147/DDDT.S427530.
Reynolds R, Yeung H, Cheng C, Cook F, Desai S, Druby K, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2024; 90(5):1006.e1-1006.e30. doi: 10.1016/j.jaad.2023.12.017.
Zaenglein A, Pathy A, Schlosser B, Alikhan A, Baldwin H, Berson D, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74(5):945-73.e33. doi: 10.1016/j.jaad.2015.12.037.
Hauk L. Acne Vulgaris: Treatment guidelines from the AAD. Am Fam Physician 2017; 95(11):740-1.
Bagatin E, Costa C, Rocha M, Picosse F, Kamamoto C, Pirmez R, et al. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol 2020; 95(Suppl 1):19-38. doi: 10.1016/j.abd.2020.09.001.
Thiboutot D, Dréno B, Abanmi A, Alexis A, Araviiskaia E, Barona M, et al. Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2018; 78(2 Suppl 1):S1-S23.e1. doi: 10.1016/j.jaad.2017.09.078.
Millan S, Flowers F, Sherertz E. Isotretinoin. South Med J 1987; 80(4):494-9. doi: 10.1097/00007611-198704000-00021.
Neudorfer M, Goldshtein I, Shamai O, Chodick G, Dadon Y, Shalev V. Ocular adverse effects of systemic treatment with isotretinoin. Arch Dermatol 2012; 148(7):803-8. doi: 10.1001/archdermatol.2012.352.
Layton A. The use of isotretinoin in acne. Dermatoendocrinol 2009; 1(3):162-9. doi: 10.4161/derm.1.3.9364.
Rademaker M. Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin. Australas J Dermatol 2010; 51(4):248-53. doi: 10.1111/j.1440-0960.2010.00657.x.
McLane J. Analysis of common side effects of isotretinoin. J Am Acad Dermatol 2001; 45(5):S188-94. doi: 10.1067/mjd.2001.113719.
Spring L, Krakowski A, Alam M, Bhatia A, Brauer J, Cohen J, et al. Isotretinoin and timing of procedural interventions: a systematic review with consensus recommendations. JAMA Dermatol 2017; 153(8):802-9. doi: 10.1001/jamadermatol.2017.2077.
Barbieri J, Shin D, Wang S, Margolis D, Takeshita J. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time. J Am Acad Dermatol 2020; 82(1):72-9. doi: 10.1016/j.jaad.2019.06.025.
Uruguay. Ministerio de Salud Pública. FO-13221-015 Declaración Jurada del Médico Tratante para el uso Isotretinoina. Montevideo; MSP, 2024.
Sundström A, Alfredsson L, Sjölin G, Gerdén B, Bergman U, Jokinen J. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 2010; 341:c5812. doi: 10.1136/bmj.c5812.
Marqueling A, Zane L. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2005; 24(2):92-102. doi: 10.1016/j.sder.2005.04.003.
Yang Y, Tu H, Hong C, Chang W, Fu H, Ho J, et al. Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study. Biomed Res Int 2014; 2014:504279. doi: 10.1155/2014/504279.
Rowe C, Spelman L, Oziemski M, Ryan A, Manoharan S, Wilson P, et al. Isotretinoin and mental health in adolescents: Australian consensus. Australas J Dermatol 2014; 55(2):162-7. doi: 10.1111/ajd.12117.
Huang Y, Cheng Y. Isotretinoin treatment for acne and risk of depression: A systematic review and meta-analysis. J Am Acad Dermatol 2017; 76(6):1068-1076.e9. doi: 10.1016/j.jaad.2016.12.028.
Chiu A, Chuenkongkaew W, Cornblath W, Trobe J, Digre K, Dotan S, et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998; 126(1):116-21. doi: 10.1016/s0002-9394(98)00063-4.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Archives of Pediatrics of Uruguay